Loading organizations...

§ Private Profile · Arroyo Grande, CA, USA
Rx Redefined is a technology company.
Rx Redefined is a compliance-focused DMEPOS platform that enables physicians to provide timely, patient-centered care while reducing time-to-service and eliminating financially motivated product switches.
Rx Redefined has raised $13.0M across 3 funding rounds.
Rx Redefined has raised $13.0M in total across 3 funding rounds.
Rx Redefined is a health tech company that builds a patented platform enabling physicians to directly manage the distribution of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) to patients, ensuring regulatory compliance and simplifying ordering.[1][2][3] It serves physicians, group practices, and patients in the healthcare sector by solving inefficiencies in traditional supply chains—like intermediary delays, non-patient-centric product pushes, and compliance burdens—while integrating with EMR systems and handling revenue cycle management.[1][2][3] The company, founded in 2017 and headquartered in Arroyo Grande, California, has raised $13.2M total (including an $8M Series A in 2023 led by Crosscut Ventures), achieved 10x booked sales growth and 450% physician population increase in the prior year, and generates around $12.4M in revenue with 59 employees.[1][4]
Rx Redefined emerged from founder and CEO Brandon Boots' decade of experience in the medical device industry, where he witnessed persistent issues like bait-and-switch tactics, delivery delays, disregard for patient needs, and rising burdens on practices.[2] Frustrated, Boots developed the idea for a physician-controlled platform to cut out intermediaries, improve care quality, reduce costs, and close patient care gaps; the company was formally founded in 2017 (with some sources noting 2018 activity).[1][2][4] Key early leaders include CTO Erik Smith and CCO Jayme Hanson, and pivotal moments include a $2M seed round in 2021 led by Silverton Partners, followed by the $8M Series A in January 2023, which fueled sales acceleration, efficiency gains, and product expansion after distributing millions of products.[1][2]
Rx Redefined rides the wave of health tech digitization in DMEPOS—a $50B+ U.S. market plagued by fragmentation, regulatory hurdles, and post-COVID supply chain strains—by empowering physicians amid rising value-based care and cost pressures.[1][2][3] Timing aligns with telehealth expansion, EMR adoption, and payer demands for compliance, positioning it to capture share from legacy distributors as practices seek integrated, patient-first solutions.[1][3] It influences the ecosystem by enabling physician-owned suppliers, reducing care gaps, and modeling tech-driven compliance, potentially accelerating similar platforms in medtech distribution.[2][5]
Rx Redefined's momentum—post-Series A expansion and demonstrated scalability—positions it to deepen physician adoption and enter adjacent DMEPOS categories amid ongoing regulatory evolution and AI-enhanced billing trends.[1][3] Expect growth via partnerships with larger practices or EMR giants, further audit-proofing innovations, and potential Series B to scale nationally, amplifying its role in redefining patient-centric supply chains. This builds on its core strength: turning physician frustration into compliant, efficient care delivery.[2]
Rx Redefined has raised $13.0M in total across 3 funding rounds.
Rx Redefined's investors include Crosscut Ventures, Comal Ventures, Ecliptic Capital, GE Ventures, Forest Baskett, Greg Papadopoulos, Jeff Immelt, New Enterprise Associates, Osage University Partners, Silverton Partners, Jaffray Woodriff, Pisgah Fund.
Rx Redefined has raised $13.0M across 3 funding rounds. Most recently, it raised $8.0M Series A in September 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 1, 2022 | $8M Series A | Crosscut Ventures | Comal Ventures, Ecliptic Capital, GE Ventures, Forest Baskett, Greg Papadopoulos, Jeff Immelt, NEW Enterprise Associates, Osage University Partners, Silverton Partners, Jaffray Woodriff, Pisgah Fund, Tusk Venture Partners | Announced |
| Jun 1, 2021 | $3M Series U | — | Ecliptic Capital, Silverton Partners | Announced |
| Feb 1, 2021 | $2M Seed | Silverton Partners | Ecliptic Capital, Saturn Five | Announced |